Cargando…

Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series

Prurigo nodularis is a pruritic skin condition that can present therapeutic challenges. We present a series of three patients diagnosed with prurigo nodularis who had failed several commonly trialed therapies, but experienced relief from symptoms and improvement in skin lesions following initiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieser, Jill K, Mercurio, Mary Gail, Somers, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377018/
https://www.ncbi.nlm.nih.gov/pubmed/32714676
http://dx.doi.org/10.7759/cureus.8737
_version_ 1783562140587655168
author Wieser, Jill K
Mercurio, Mary Gail
Somers, Kathryn
author_facet Wieser, Jill K
Mercurio, Mary Gail
Somers, Kathryn
author_sort Wieser, Jill K
collection PubMed
description Prurigo nodularis is a pruritic skin condition that can present therapeutic challenges. We present a series of three patients diagnosed with prurigo nodularis who had failed several commonly trialed therapies, but experienced relief from symptoms and improvement in skin lesions following initiation of dupilumab therapy. All patients in this series lacked a diagnosis of atopic dermatitis and had lesions on the lower extremities, although other locations such as the trunk were also involved. Continued study of dupilumab in patients with prurigo nodularis is advocated.
format Online
Article
Text
id pubmed-7377018
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-73770182020-07-24 Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series Wieser, Jill K Mercurio, Mary Gail Somers, Kathryn Cureus Dermatology Prurigo nodularis is a pruritic skin condition that can present therapeutic challenges. We present a series of three patients diagnosed with prurigo nodularis who had failed several commonly trialed therapies, but experienced relief from symptoms and improvement in skin lesions following initiation of dupilumab therapy. All patients in this series lacked a diagnosis of atopic dermatitis and had lesions on the lower extremities, although other locations such as the trunk were also involved. Continued study of dupilumab in patients with prurigo nodularis is advocated. Cureus 2020-06-21 /pmc/articles/PMC7377018/ /pubmed/32714676 http://dx.doi.org/10.7759/cureus.8737 Text en Copyright © 2020, Wieser et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Wieser, Jill K
Mercurio, Mary Gail
Somers, Kathryn
Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
title Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
title_full Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
title_fullStr Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
title_full_unstemmed Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
title_short Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
title_sort resolution of treatment-refractory prurigo nodularis with dupilumab: a case series
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377018/
https://www.ncbi.nlm.nih.gov/pubmed/32714676
http://dx.doi.org/10.7759/cureus.8737
work_keys_str_mv AT wieserjillk resolutionoftreatmentrefractoryprurigonodulariswithdupilumabacaseseries
AT mercuriomarygail resolutionoftreatmentrefractoryprurigonodulariswithdupilumabacaseseries
AT somerskathryn resolutionoftreatmentrefractoryprurigonodulariswithdupilumabacaseseries